Japanese drugmaker Astellas Pharma has agreed to buy US bioelectronics startup Iota Biosciences. The move follows their R&D agreement signed in August 2019, under which...
16.08.2018
- Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. The acquisition...
28.06.2017
- The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its...
08.06.2015
- On June 2, The International Society for Pharmaceutical Engineering (ISPE) formally appreciated its 2015 Facility of the Year Awards (FOYA) category winners at a banquet in...
03.11.2014
- Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...
21.11.2013
- The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it...
18.07.2013
- China announced a nationwide crackdown on the sale of illegal medicine on Wednesday and said it would tighten industry regulation, piling pressure on a sector already reeling from...
19.04.2013
- Japan's Astellas Pharma and Britain's GlaxoSmithKline are competing to develop a new kind of medicine that boosts production of red blood cells by making the body think it is at...
